These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 19837296

  • 1. Foot and mouth disease virus vaccines.
    Rodriguez LL, Grubman MJ.
    Vaccine; 2009 Nov 05; 27 Suppl 4():D90-4. PubMed ID: 19837296
    [Abstract] [Full Text] [Related]

  • 2. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ.
    Biologicals; 2005 Dec 05; 33(4):227-34. PubMed ID: 16289996
    [Abstract] [Full Text] [Related]

  • 3. Development of vaccines toward the global control and eradication of foot-and-mouth disease.
    Rodriguez LL, Gay CG.
    Expert Rev Vaccines; 2011 Mar 05; 10(3):377-87. PubMed ID: 21434805
    [Abstract] [Full Text] [Related]

  • 4. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X, Liu R, Tang H, Jin M, Chen H, Qian P.
    Vaccine; 2008 May 23; 26(22):2714-22. PubMed ID: 18436351
    [Abstract] [Full Text] [Related]

  • 5. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
    Blignaut B, Visser N, Theron J, Rieder E, Maree FF.
    J Gen Virol; 2011 Apr 23; 92(Pt 4):849-59. PubMed ID: 21177923
    [Abstract] [Full Text] [Related]

  • 6. Novel approaches to foot-and-mouth disease vaccine development.
    Ludi A, Rodriguez L.
    Dev Biol (Basel); 2013 Apr 23; 135():107-16. PubMed ID: 23689888
    [Abstract] [Full Text] [Related]

  • 7. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P, Li XM, Jin ML, Peng GQ, Chen HC.
    Vaccine; 2004 Jun 02; 22(17-18):2129-36. PubMed ID: 15149769
    [Abstract] [Full Text] [Related]

  • 8. [Expression of foot and mouth disease virus antigens in transgenic plants].
    Dus Santos MJ, Wigdorovitz A.
    Rev Sci Tech; 2005 Apr 02; 24(1):175-87. PubMed ID: 16110887
    [Abstract] [Full Text] [Related]

  • 9. Past and present vaccine development strategies for the control of foot-and-mouth disease.
    Balamurugan V, Kumar RM, Suryanarayana VV.
    Acta Virol; 2004 Apr 02; 48(4):201-14. PubMed ID: 15745043
    [Abstract] [Full Text] [Related]

  • 10. Selection of foot and mouth disease vaccine strains--a review.
    Paton DJ, Valarcher JF, Bergmann I, Matlho OG, Zakharov VM, Palma EL, Thomson GR.
    Rev Sci Tech; 2005 Dec 02; 24(3):981-93. PubMed ID: 16642769
    [Abstract] [Full Text] [Related]

  • 11. Antigen and vaccine banks: technical requirements and the role of the european antigen bank in emergency foot and mouth disease vaccination.
    Lombard M, Füssel AE.
    Rev Sci Tech; 2007 Apr 02; 26(1):117-34. PubMed ID: 17633297
    [Abstract] [Full Text] [Related]

  • 12. The eradication of foot-and-mouth disease: a parallel problem.
    Brown F.
    Dev Biol (Basel); 2001 Apr 02; 105():123-7; discussion 149-50. PubMed ID: 11763321
    [Abstract] [Full Text] [Related]

  • 13. Engineering better vaccines for foot-and-mouth disease.
    Mason PW, Chinsangaram J, Moraes MP, Mayr GA, Grubman MJ.
    Dev Biol (Basel); 2003 Apr 02; 114():79-88. PubMed ID: 14677679
    [Abstract] [Full Text] [Related]

  • 14. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
    Ren ZJ, Tian CJ, Zhu QS, Zhao MY, Xin AG, Nie WX, Ling SR, Zhu MW, Wu JY, Lan HY, Cao YC, Bi YZ.
    Vaccine; 2008 Mar 10; 26(11):1471-81. PubMed ID: 18289743
    [Abstract] [Full Text] [Related]

  • 15. [Vaccination against foot and mouth disease: current state and perspectives].
    Visser N, Thiel HJ.
    Dtsch Tierarztl Wochenschr; 2001 Dec 10; 108(12):522-5. PubMed ID: 11822168
    [Abstract] [Full Text] [Related]

  • 16. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
    Du Y, Dai J, Li Y, Li C, Qi J, Duan S, Jiang P.
    Vet Immunol Immunopathol; 2008 Aug 15; 124(3-4):274-83. PubMed ID: 18511133
    [Abstract] [Full Text] [Related]

  • 17. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.
    Fowler VL, Paton DJ, Rieder E, Barnett PV.
    Vaccine; 2008 Apr 07; 26(16):1982-9. PubMed ID: 18342409
    [Abstract] [Full Text] [Related]

  • 18. Developing Vaccines Against Foot-and-Mouth Disease: a Biotechnological Approach.
    Shahriari A, Habibi-Pirkoohi M.
    Arch Razi Inst; 2018 Dec 07; 73(1):1-10. PubMed ID: 30256033
    [Abstract] [Full Text] [Related]

  • 19. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
    Zheng M, Jin N, Zhang H, Jin M, Lu H, Ma M, Li C, Yin G, Wang R, Liu Q.
    J Virol Methods; 2006 Sep 07; 136(1-2):230-7. PubMed ID: 16780963
    [Abstract] [Full Text] [Related]

  • 20. Foot-and-mouth disease vaccines: progress and problems.
    Cao Y, Lu Z, Liu Z.
    Expert Rev Vaccines; 2016 Jun 07; 15(6):783-9. PubMed ID: 26760264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.